Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €153.67 EUR
Change Today -0.097 / -0.06%
Volume 0.0
As of 3:24 PM 07/6/15 All times are local (Market data is delayed by at least 15 minutes).

cr bard inc (BR6) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/24/15 - €165.85
52 Week Low
07/18/14 - €104.63
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for CR BARD INC (BR6)

cr bard inc (BR6) Related Businessweek News

No Related Businessweek News Found

cr bard inc (BR6) Details

C. R. Bard, Inc. designs, manufactures, packages, distributes, and sells medical, surgical, diagnostic, and patient care devices worldwide. The company offers vascular products, such as percutaneous transluminal angioplasty catheters, chronic total occlusion catheters, guidewires, fabrics, meshes, introducers, and accessories; valvuloplasty balloons; peripheral vascular stents, self-expanding and balloon-expandable covered stents, and vascular grafts; vena cava filters; biopsy devices; and temporary pacing electrode catheters for the treatment of peripheral vascular disease and heart arrhythmias. It also provides urology products, including Foley catheters to reduce the rate of urinary tract infections; fecal incontinence products; brachytherapy devices and radioactive seeds for the treatment of prostate cancer; intermittent urinary drainage catheters, and urine monitoring and collection systems; ureteral stents; specialty devices for stone removal procedures; surgical slings and pelvic floor repair products; catheter stabilization devices; and products for therapeutic hypothermia. In addition, the company offers oncology products that include specialty vascular access catheters and ports, vascular access ultrasound devices, dialysis access catheters, and enteral feeding devices to treat and manage various cancers, and other diseases and disorders. Further, it provides surgical specialty products comprising implanted grafts and fixation devices for hernia and soft tissue repairs; and hemostats and surgical sealants, as well as other products, such as irrigation, wound drainage, and original equipment manufacturers’ products. The company sells its products directly to hospitals, individual healthcare professionals, extended care facilities, and alternate site facilities. C. R. Bard, Inc. was founded in 1907 and is headquartered in Murray Hill, New Jersey.

13,900 Employees
Last Reported Date: 02/18/15
Founded in 1907

cr bard inc (BR6) Top Compensated Officers

Chairman, Chief Executive Officer and Chairma...
Total Annual Compensation: $1.1M
President, Chief Operating Officer and Direct...
Total Annual Compensation: $887.0K
Chief Financial Officer and Senior Vice Presi...
Total Annual Compensation: $594.5K
Group President
Total Annual Compensation: $594.5K
Group President
Total Annual Compensation: $592.1K
Compensation as of Fiscal Year 2014.

cr bard inc (BR6) Key Developments

CR Bard Inc. Presents at Piper Jaffray Heartland Summit, Jun-23-2015

CR Bard Inc. Presents at Piper Jaffray Heartland Summit, Jun-23-2015 . Venue: Minneapolis, Minnesota, United States. Speakers: Timothy M. Ring, Chairman, Chief Executive Officer and Chairman of Executive Committee.

C. R. Bard, Inc. Announces Quarterly Dividend, Payable on July 31, 2015

The Board of Directors of C. R. Bard Inc. increased the quarterly dividend on Bard's common stock by 9%, to 24 cents per share. The dividend is payable on July 31, 2015 to shareholders of record at the close of business on July 20, 2015.

CR Bard Mulls Acquisitions

CR Bard Inc. (NYSE:BCR) intends to continue to be acquisitive as a buyer and consolidator in the specialty pharmaceutical space.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BR6:GR €153.67 EUR -0.097

BR6 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Coloplast A/S kr435.70 DKK -1.90
Edwards Lifesciences Corp $145.12 USD +2.67
Endo International PLC $81.58 USD -0.44
Mettler-Toledo International Inc $346.13 USD -0.33
Terumo Corp ¥3,075 JPY +45.00
View Industry Companies

Industry Analysis


Industry Average

Valuation BR6 Industry Range
Price/Earnings 46.5x
Price/Sales 3.8x
Price/Book 7.3x
Price/Cash Flow 44.5x
TEV/Sales 3.0x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CR BARD INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at